Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 51 citing articles:

Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis
Marco Zuin, Stefano Barco, George Giannakoulas, et al.
Journal of Thrombosis and Thrombolysis (2023) Vol. 55, Iss. 3, pp. 490-498
Open Access | Times Cited: 39
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19
Sam Schulman, Donald M. Arnold, Charlotte Bradbury, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 6, pp. 1779-1797
Open Access | Times Cited: 18
Treatments for COVID-19
Hayden S. Andrews, Jonathan D. Herman, Rajesh T. Gandhi
Annual Review of Medicine (2023) Vol. 75, Iss. 1, pp. 145-157
Closed Access | Times Cited: 25
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment
Luis Ortega‐Paz, Azita H. Talasaz, Parham Sadeghipour, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 08, pp. 816-832
Open Access | Times Cited: 28
Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial
Gregory Piazza, Alex C. Spyropoulos, Judith Hsia, et al.
Circulation (2023) Vol. 147, Iss. 25, pp. 1891-1901
Open Access | Times Cited: 20
Outpatient randomized controlled trials to reduce COVID‐19 hospitalization: Systematic review and meta‐analysis
David J. Sullivan, Daniele Focosi, Daniel F. Hanley, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 12
Open Access | Times Cited: 19
SARS-CoV-2 infection in pregnant women and incidence of thromboembolic disease – an analysis of the Covid-19 Related Obstetric and Neonatal Outcome Study (CRONOS) in Germany
Ulrich Pecks, Michael K. Bohlmann, Kristin Andresen, et al.
Research Square (Research Square) (2025)
Closed Access
Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood
Riten Kumar, Michael J. Rivkin, Leslie Raffini
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 9, pp. 2313-2326
Open Access | Times Cited: 13
Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials
Konstantinos G. Kyriakoulis, Evangelos Dimakakos, Ioannis Kyriakoulis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 20, pp. 5997-5997
Open Access | Times Cited: 19
Uncertainties about the roles of anticoagulation and microclots in postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection
Jean M. Connors, Robert A. S. Ariëns
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 10, pp. 2697-2701
Closed Access | Times Cited: 11
Prophylactic anticoagulants for non-hospitalised people with COVID-19
Brena Costa Santos, Ronald Luiz Gomes Flumignan, Vinicius Tassoni Civile, et al.
Cochrane library (2023) Vol. 2023, Iss. 8
Open Access | Times Cited: 11
Designing Future Clinical Trials for Sepsis-associated Disseminated Intravascular Coagulation
Cheryl L. Maier, Toshiaki Iba
Juntendo Medical Journal (2024) Vol. 70, Iss. 2, pp. 125-128
Open Access | Times Cited: 3
Anticoagulation in COVID-19 patients – An updated systematic review and meta-analysis
Stefanie Reis, Amon Faske, Ina Monsef, et al.
Thrombosis Research (2024) Vol. 238, pp. 141-150
Open Access | Times Cited: 3
The Preventive and Therapeutic Effects of Acute and Severe Inflammatory Disorders with Heparin and Heparinoid
Ying Song, Wu Yuxiang, Fangfang Ding, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1078-1078
Open Access | Times Cited: 3
Outpatient regimens to reduce COVID-19 hospitalisations: a systematic review and meta-analysis of randomized controlled trials
David J. Sullivan, Daniele Focosi, Daniel F. Hanley, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 16
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
John W. Eikelboom, Sanjit S. Jolly, Emilie P. Belley‐Côté, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 12, pp. 1160-1168
Open Access | Times Cited: 16
Pathological Effects of SARS-CoV-2 Associated with Hematological Abnormalities
Shama Shama, Asif Mahmood, Shahid Mehmood, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 9, pp. 7161-7182
Open Access | Times Cited: 9
Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial
Davide Voci, Andrea Götschi, Ulrike Held, et al.
Thrombosis Research (2022) Vol. 221, pp. 157-163
Open Access | Times Cited: 15
Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance
Gaetano Scaramuzzo, Francesco Nucera, Alessio Asmundo, et al.
Journal of Inflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Low molecular weight heparin in COVID-19: benefits and concerns
Adham Makarem, Rana Zareef, Joseph Abourjeili, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Role of Therapeutic Anticoagulation in COVID-19: The Current Situation
Mandeep Singh Rahi, Jay Parekh, Prachi Pednekar, et al.
Hematology Reports (2023) Vol. 15, Iss. 2, pp. 358-369
Open Access | Times Cited: 6
A Literature Review of Pathophysiology, Clinical Manifestations, Medications and Optimal Dosage, Outpatient, and Post-hospitalization Use of Anticoagulation in COVID-19 Patients
Dimitrios Velissaris, Christos Michailides, Iosif Karalis, et al.
The Anatolian Journal of Cardiology (2023), pp. 232-239
Open Access | Times Cited: 5
Uncertainties about the roles of anticoagulation and microclots in post-acute sequelae of SARS-CoV-2 infection—response to the letter by Kell et al.
Jean M. Connors, Robert A. S. Ariëns
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 2, pp. 569-571
Open Access | Times Cited: 1
The impacts of prophylactic anticoagulation therapy during hospitalization on long-term cardiovascular outcomes in high-risk COVID-19 patients amid the omicron wave of the pandemic
Jun Gu, Yue Wang, Junfeng Zhang, et al.
IJC Heart & Vasculature (2024) Vol. 50, pp. 101353-101353
Open Access | Times Cited: 1
Safety and efficacy of antithrombotics in outpatients with symptomatic COVID-19: A systematic review and meta-analysis
Saad Ali Ansari, Nooraldin Merza, Madiha Salman, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 4, pp. 102451-102451
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top